The Journal of Bone and Joint Surgery (American). 2007;89:1970-1978.
doi:10.2106/JBJS.F.01591
© 2007 The Journal of Bone and Joint Surgery, Inc.
The Quality of Reporting of Orthopaedic Randomized Trials with Use of a Checklist for Nonpharmacological Therapies
Simon Chan, BSc1 and
Mohit Bhandari, MD1
1 Hamilton Health Sciences-General Hospital, 237 Barton Street East, 7 North
Wing, Suite 727, Hamilton, ON L8L 2X2, Canada. E-mail address for M. Bhandari:
bhandam{at}mcmaster.ca
Investigation performed at the Division of Orthopaedic Surgery,
McMaster University, Hamilton, Ontario, Canada
Disclosure: In support of their research for or preparation of this
work, one or more of the authors received, in any one year, outside funding or
grants of less than $10,000 from the Canadian Institutes of Health Research
and of more than $10,000 from a Canada Research Chair and McMaster University.
Neither they nor a member of their immediate families received payments or
other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, division, center,
clinical practice, or other charitable or nonprofit organization with which
the authors, or a member of their immediate families, are affiliated or
associated.
Background: The Consolidated Standards of Reporting Trials statement
for the reporting of randomized controlled trials has been limited by its
applicability to surgical trials. In response, a Checklist to Evaluate a
Report of a Nonpharmacological Trial was recently developed by the
Consolidated Standards of Reporting Trials group to address reporting issues
in surgical trials. We aimed (1) to apply the checklist for nonpharmacological
therapies to orthopaedic randomized controlled trials across multiple journals
from 2004 through 2005, and (2) to survey authors when methodological
safeguards itemized in the checklist were not reported to determine whether
they actually had been performed. We hypothesized that lack of reporting of a
methodological safeguard did not necessarily mean it had not been
conducted.
Methods: We searched for relevant orthopaedic randomized controlled
trials across eight journals in the period from January 2004 through December
2005. We applied the Checklist to Evaluate a Report of a Nonpharmacological
Trial to all eligible studies. We contacted authors to determine what
methodological safeguards were actually used, especially when details remained
unclear from the publication.
Results: We included eighty-seven randomized controlled trials from
eighty-five scientific reports. In assessing the randomized controlled trials
with the checklist for nonpharmacological therapies, seventy-three studies
(84%) had unclear reporting of treatment allocation concealment. Only
seventeen studies (20%) mentioned surgeon skill or experience. The blinding of
patients, ward staff, rehabilitation staff, clinical outcome assessors, and
nonclinical outcome assessors was unclear in forty-eight (55%), sixty-three
(72%), sixty-four (74%), forty (46%), and thirty-three studies (38%),
respectively. Authors from forty-three randomized controlled trials responded
to our survey. The results of the survey showed that 41% (95% confidence
interval, 25% to 58%) of the trials had adequate allocation concealment when
this had been unclear from the report. Although the surgical experience of the
investigators was rarely reported, most authors (70%) acknowledged that they
had defined "surgical expertise criteria" such as minimum case
criteria, specialized training, and clinical performance. The survey also
showed that 28% to 40% of the trials had blinding of relevant groups despite
the fact that the reporting of such blinding had been unclear in the
publications.
Conclusions: The quality of reporting in the orthopaedic literature
was highly variable. Readers should not assume that bias-reducing safeguards
that were not reported in a randomized controlled trial did not occur. Our
study reinforces the need for the consistent use of a tool like the Checklist
to Evaluate a Report of a Nonpharmacological Trial to assess the methodology
of surgical trials.

CiteULike Connotea Del.icio.us Technorati What's this?
|